FDA Launches #NaloxoneApp Competition to Spur Innovative Technologies to Help Reduce Opioid Overdose Deaths
The U.S. Food and Drug Administration has announced the 2016 Naloxone App Competition, a public contest focused on developing innovative technologies to combat the rising epidemic of opioid overdose. The FDA, with support from the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), is inviting computer programmers, public health advocates, clinical researchers, entrepreneurs and innovators from all disciplines to 
Royal Philips (NYSE: PHG, AEX: PHIA) has unveiled its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which was held in Barcelona (Spain) from September 10 until 14. Philips' next generation interventional oncology solution OncoSuite will enable physicians to provide analysis and minimally invasive, targeted treatment of tumor lesions reducing the impact to healthy tissue. 
Pfizer Inc. (NYSE:PFE) has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression. Depression is one of the most common mental health disorders in the United States, as an estimated one in 15 adults (6.7%) experience at least one major depressive episode in any given year. 
Sanofi and Verily Life Sciences LLC, (formerly Google Life Sciences), an Alphabet company, have announced the launch of Onduo, a joint venture created through Sanofi and Verily's diabetes-focused collaboration. The joint venture is based in Kendall Square in Cambridge. Onduo's mission is to help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management. 
The Royal Wolverhampton NHS Trust (RWT) has completed a successful data migration and archive project, supported by healthcare data specialist Stalis, to centralise patient demographic and scheduling information, helping to deliver more coordinated and efficient patient care. The project included safely and securely transferring patient data from the trust's Community Services IT system to its central Patient Administration System (PAS). 
Taunton and Somerset NHS Foundation Trust (FT) is one of 12 trusts that has been named by Government as a Global Digital Exemplar in the NHS. The trust will receive up to £10 million of funding over the next two years to pioneer digital excellence and share best practice. 
Allscripts (NASDAQ:MDRX) announced today its latest initiative to improve population health, Allscripts eRecruitTM services. This multi-faceted initiative will offer services and technology to support physicians with referring patients to clinical trials, and life sciences and clinical research organizations to reduce clinical studies' time and cost. This, in turn will help bring new treatments to the market more quickly.